Replicon-based vectors of positive strand RNA viruses

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 5, 2000, Pages 555-569

  Khromykh, A A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cancer therapy; Heterologous gene expression; Positive strand RNA viruses; Replicon based vectors; Vaccines; Virus like particles

Indexed keywords

CANCER VACCINE; VIRUS RNA; VIRUS VACCINE;

ALPHA VIRUS; EXPRESSION VECTOR; FLAVIVIRUS; GENE AMPLIFICATION; GENE EXPRESSION; GENE TECHNOLOGY; NONHUMAN; PICORNAVIRUS; REPLICON; REVIEW; RNA VIRUS; VIRAL GENETICS; VIRUS GENE;

ALPHAVIRUS; ANIMALS; CELL LINE; DNA, VIRAL; FLAVIVIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; HUMANS; NEOPLASMS; PICORNAVIRIDAE; POLIOVIRUS; REPLICON; RNA VIRUSES; RNA, VIRAL; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0033744135     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. RNA viruses: Emerging vectors for vaccination and gene therapy
2. A new generation of animal cell expression vectors based on the Semllki Forest virus replicon
3. Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs
4. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogenes in vivo
5. Expression of human immunodeficlency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons
6. Subgenomlc replicons of the flavivirus Kunjin: Construction and applications
7. The alphaviruses: Gene expression, replication and evolution
8. A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene
9. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity In BHK cells
10. Pollovirus assembly and encapsidation of genomic RNA
11. Construction and characterization of pollovirus subgenomic replicons
12. Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA
13. Release of virus-like particles from cells infected with pollovirus replicons which express human immunodaficiency virus type 1 Gag
14. Taxonomy and evolutionary relationships of flaviviruses
15. Characterization of an autonomous subgenomic pestivirus RNA replicon
16. Establishment and characterization of cytopathogenic and non-cytopathogenic pestivirus replicons
17. Cytopathogenic and non-cytopathogenic RNA replicons of classical swine fever virus
18. Replication of subganomic hepatitis C virus RNAs in a hepatoma cell line
19. Engineering yellow fever 17D for heterologous gene expression and vaccination
20. Non-cytopathic flavivirus replicon RNA-based system for expression and delivery of hetarologous genes
21. Stable high-level expression of heterologous genes in vitro and in vivo by non-cytopathic DNA-based Kunjin virus replicon vectors
22. Nucleotide and complete amino acid sequences of Kunjin virus: Definitive gene order and characteristics of the virus-specified proteins
23. A Sindbis virus mRNA polynucleotide vector achieves prolonged and high-level heterologous gene expression in vivo
24. Cancer therapy using a self-replicating RNA vaccine
25. Sindbis virus replicons and Sindbis virus: Assembly of chimeras and of particles deficient in virus RNA
26. Two-helper RNA system for production of recombinant Semliki forest virus particles
27. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors
28. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans
29. Encapsdation of the flavivirus Kunjin raplicon RNA by using a complementation system providing Kunjin virus structural proteins in trans
30. Sindbis virus DNA-based expression vectors: Utility for in vitro and in vivo gene transfer
31. Rapid, high-level protein production using DNA-based Semliki Forest virus vectors
32. Enhancing immune responses using suicidal DNA vaccines
33. Cloned poliovirus complementary DNA is infectious in mammalian cells
34. Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals
35. Comparison of various expression plasmids for the induction of immune response by DNA immunization
36. DNA immunization against herpes simplex virus: Enhanced efficacy using a Sindbis virus-based vector
37. Comparison of the protective efficacy of naked DNA, DHA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters
38. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors
39. Pollovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14
40. Non-cytopathic Sindbis virus RNA vectors for hetarologous gene expression
41. Selection of RNA replicons capable of persistent non-cytopathic replication in mammalian cells
42. Trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells
43. Cis- and trans-acting elements in flavivirus RNA replication
44. Regulated expression of a Sindbis virus replicon by herpesvirus promoters
45. Alphavirus vectors for gene expression and vaccines
46. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
47. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
48. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins
49. Immunization of mice with poliovirus replicons expressing the C-fragment of tatsnus toxin protects against lethal challenge with tetanus toxin
50. Pollovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1-associated immune response
51. Interferons and other cytokines
52. A double stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis
53. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
54. Cytotoxic T-cell immunity to virus-infectad non-haematopoietic cells requires presentation of exogenous antigen
55. Natural adjuvants: Endogenous activators of dendritic cells
56. Stratesgias involved in developing an effective vaccine for EBV-associatad diseases
57. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistsnt prostitutes in Nairobi
58. Is cancer dangerous to the immune system?
59. The dendritic cell system and its role in immunogenicity
60. A viral vaccine vector that expresses foreign genes In lymph nodes and protects against mucosal challenge
61. Lengerhans cells migrate to local lymph nodes following cutaneous Infection with an arbovirus
62. Human skin Lengerhans cells are targets of dengue virus infection
63. Role of dendritic cell targeting In Venezuelan equine ancephalitis virus pathogenesis
64. Induction of P815 tumor immunity by recombinant Semlikl Forest virus expressing the P1A gene
65. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography
66. Cell-specific targeting of a thymidine kineselganciclovir gene therapy system using a recombinant Sindbts virus vector
67. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures
68. Efficient gene delivery into adult cardiomyocytes by recombinant Sindbis virus
69. Reducing cytotoxicity induced by Sindbis viral vectors
70. Preliminary analysis of murine cytotoxic T-cell responses to the proteins of the flavivlrus Kunjln using vaccinia virus expression
71. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T-lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities
72. Flavivirus expression and delivery system